Annual report highlights and a £28 million reverse takeover
Technologies New Energy plc has published its Annual Report for the year ended 31 December 2024 and, more importantly for investors, confirmed completion of a £28 million reverse takeover of Technologies New Energy S.A. in April 2025. That transaction turns TNE from a cash shell into an operating renewable energy group. You can find the full documents via the FCA’s National Storage Mechanism and the company’s investors page.
Below I break down the numbers, the deal mechanics, and what it means for the equity story from here.
From cash shell to operating company: what has changed
TNE was set up to acquire a business in the renewable energy sector. Mission accomplished: on 30 April 2025 it completed the acquisition of Technologies New Energy S.A. for £28 million, paid entirely in new shares at a reference price of £0.20 per share. This is a reverse takeover – a transaction where a smaller listed company buys a larger private one, effectively bringing the private business to market.
Since year end, TNE has also bought Diverfuel S.A. (28 August 2025), the developer of the Diverfuel Platform, which is now a wholly-owned subsidiary. Post-deal, TNE has shifted its accounting year-end from 31 December to 30 April and then back to 31 December to align with Diverfuel S.A. It’s fair to say the corporate housekeeping reflects a business transitioning into a growth phase.
Key numbers investors should know
| Metric | Figure | Date/Notes |
|---|---|---|
| Reverse takeover consideration | £28.0 million | All-share at £0.20 reference price |
| Shares issued for RTO | 140,000,000 | 30 April 2025 |
| Cash balance | £297,201 | 31 December 2024 |
| Cash balance (Enlarged Group) | £778,510 | 28 August 2025 |
| Loss before tax | £502,491 | Year to 31 December 2024 |
| Net assets | £29,348 | 31 December 2024 |
| New equity raised | £400,000 | April 2025 subscription at £0.20 |
| New equity raised | £84,900 | 3 July 2025 subscription at £0.20 |
| Warrants | Exercise price cut to £0.10 | 4 June 2025 – exercise periods extended by 12 months |
| Revenue | None | Pre-RTO period |
Financial performance and cash runway
The 2024 numbers reflect a pre-revenue cash shell. There was no revenue, administrative expenses were £502,491, and the company posted a loss per share of 0.06 pence. Cash at year end was £297,201 with creditors of £274,903, leaving net assets of £29,348.
Post year end, the Enlarged Group reported cash of £778,510 as at 28 August 2025. The Board believes this is sufficient for at least the next 12 months. That said, the auditors and the Directors flag a material uncertainty around going concern, because future growth will require additional funding and there is no guarantee of raising it on favourable terms. This is standard for early-stage operators, but it is a real risk to price in.
Deal mechanics, dilution and warrants
The £28 million acquisition was satisfied entirely in shares at £0.20, which significantly enlarged the share count. Additional shares were issued for small cash raises in April and July 2025.
The warrant instrument was amended on 4 June 2025 – exercise windows extended by 12 months and the exercise price reduced from £0.20 to £0.10. That makes exercise more likely, which could be double-edged: it can provide extra cash if exercised, but it is dilutive. The RNS does not disclose the number of warrants outstanding.
Ownership concentration and free float
Insider ownership is high. As at 1 August 2025:
- José Meneses da Silva Moura and spouse held 70,420,000 Ordinary Shares in aggregate – 44.22% of issued share capital (including 70,000,000 shares or 43.95% via Diverstock Investment S.A.).
- Guimarães Eiras, Unipessoal S.A. held 42,000,000 Ordinary Shares – 26.40%.
- Tranergy Lda held 14,000,000 Ordinary Shares – 8.80%.
- Hope On board Lda held 10,500,000 Ordinary Shares – 8.80%.
High concentration can be supportive for strategic alignment, but it typically reduces free float and can amplify share price moves – both up and down.
Governance, committees and controls
The Board now comprises three executive Directors and two non-executive Directors. Post-RTO, Remuneration and Nominations Committees have been established, and the Audit Committee is chaired by Salvador Amico. Johnsons Chartered Accountants remain auditors and provided no non-audit services.
This is sensible scaffolding for a newly operational group, although the company does not fully apply the UK Corporate Governance Code due to size and resources.
Risks the Board is flagging
- Funding risk – ability to secure sufficient capital post-acquisition remains uncertain. The going concern note acknowledges a material uncertainty.
- Technology risk – the sector is competitive and fast-moving.
- Due diligence risk – not all issues may surface pre-completion.
- Reputational risk – governance or operational missteps could impact confidence.
- Execution risk – newly established group with limited operating history in its own right.
What to watch next
- Integration and commercialisation – the RNS confirms the transition to an operating company, but no revenue guidance is provided. Investors should look for early revenue wins or order backlog progress in the next update.
- Cash and funding – monitor quarterly cash movements and any new financing. The current cash is expected to cover at least 12 months, but growth plans may need more.
- Warrant activity – exercises at £0.10 could top up cash but dilute existing holders.
- Diverfuel S.A. – more detail on the platform, commercial model and expected contribution would help frame the growth thesis.
- Corporate calendar – the company has updated its year end to 31 December, so expect reporting to align accordingly.
My take: why this matters and how to frame the risk-reward
This is the line in the sand for TNE. The reverse takeover and subsequent Diverfuel deal complete the pivot from a cash shell into a functioning renewables group. That is the positive – the acquisition gives TNE something to operate, scale and report on, rather than just searching.
The trade-off is the usual early-stage cocktail: no revenue disclosed yet, a 2024 loss from listing costs and advisory spend, modest cash, and an explicit going concern caveat due to funding dependence. The warrant repricing to £0.10 increases the chance of future dilution, though it could bring in cash if sentiment improves.
If you are bullish on the team and the assets acquired, the high insider ownership suggests strong alignment. If you prioritise visibility on earnings and balance sheet strength, you will likely want to see the first operational KPIs and funding steps before leaning in.
Either way, the next set of updates should be about contracts, delivery and cash conversion – exactly what the market needs to value TNE as an operator rather than a shell. Keep an eye on the company’s investor page for those milestones.
